- Home
- BSX vs NUWE Comparison
BSX vs NUWE Comparison
Compare BSX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- NUWE
- Stock Information
- Founded
- BSX 1979
- NUWE 1999
- Country
- BSX United States
- NUWE United States
- Employees
- BSX N/A
- NUWE N/A
- Industry
- BSX Medical/Dental Instruments
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BSX Health Care
- NUWE Health Care
- Exchange
- BSX Nasdaq
- NUWE Nasdaq
- Market Cap
- BSX 157.6B
- NUWE 3.9M
- IPO Year
- BSX 1992
- NUWE N/A
- Fundamental
- Price
- BSX $102.70
- NUWE $4.18
- Analyst Decision
- BSX Strong Buy
- NUWE
- Analyst Count
- BSX 22
- NUWE 0
- Target Price
- BSX $118.91
- NUWE N/A
- AVG Volume (30 Days)
- BSX 6.6M
- NUWE 204.1K
- Earning Date
- BSX 10-22-2025
- NUWE 11-10-2025
- Dividend Yield
- BSX N/A
- NUWE N/A
- EPS Growth
- BSX 36.90
- NUWE N/A
- EPS
- BSX 1.68
- NUWE N/A
- Revenue
- BSX $18,494,000,000.00
- NUWE $8,318,000.00
- Revenue This Year
- BSX $19.75
- NUWE $6.53
- Revenue Next Year
- BSX $10.98
- NUWE $51.63
- P/E Ratio
- BSX $61.13
- NUWE N/A
- Revenue Growth
- BSX 21.44
- NUWE N/A
- 52 Week Low
- BSX $80.64
- NUWE $3.74
- 52 Week High
- BSX $109.50
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- BSX 38.78
- NUWE 28.16
- Support Level
- BSX $104.24
- NUWE $3.74
- Resistance Level
- BSX $109.50
- NUWE $4.35
- Average True Range (ATR)
- BSX 1.90
- NUWE 0.26
- MACD
- BSX -0.35
- NUWE 0.14
- Stochastic Oscillator
- BSX 3.13
- NUWE 27.16
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.